May 11, 2023
Under 40s with Mental Health Problems Have Elevated Risks of Heart Attack and Stroke
May 11, 2023 — Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a…
Read More
The randomized controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients
May 10, 2023
Oxygen Therapy Improves Heart Function in Patients with Long COVID
May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy…
Read More
This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases
May 10, 2023
Women are Underrepresented in Cardiovascular Clinical Trials
May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (…
Read More
The AIMed Global Summit will be held June 4-7, 2023, at the San Diego Convention Center, featuring a comprehensive agenda of key leaders and wide-ranging sessions on artificial intelligence (AI), its application, opportunities and implications on healthcare.
By Christine Book
May 10, 2023
AiMed Global Summit 2023 to Focus on “Changing Healthcare One Connection at a Time” in San Diego
May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered…
Read More
INSPIRIS RESILIA aortic valve
May 09, 2023
Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year Data
May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of…
Read More
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early detection of heart disease, announces completion of patient enrollment for its MyoVista wavECG pivotal study for FDA De Novo submission.
May 09, 2023
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
May 9, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical…
Read More
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiology (ACC), a first edition of a framework for the CADScor System.
May 09, 2023
Acarix and the American College of Cardiology Collaborate on First Edition Framework for CADScor System
May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the…
Read More
Marshall-Plan study presented in a late breaking science session today at EHRA 2023
May 08, 2023
Novel Ablation Strategy Improves Freedom from Arrhythmias in Atrial Fibrillation Patients
May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves…
Read More
This recent advance fulfils the requirements needed to promote an efficient translation of innovations and new treatments from the bench to the bedside in this field
May 08, 2023
New Reproducible and Minimally Invasive Stroke Model Through an Endovascular Approach
May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol…
Read More
Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3
May 08, 2023
Ucardia Announces Acquisition of PHAS3; Launches Cardiologist Practice Remote Patient Monitoring Offering
May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to…
Read More
72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.
May 05, 2023
Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption
May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a…
Read More
A new book written by and for interventional cardiologists provides a collection of detailed case studies, clinical data and imagery, according to Cedars-Sinai, whose team from Smidt Heart Institute is among the editors of the publication.
Christine Book
May 04, 2023
Book Offering Collection of Complex Interventional Cardiology Cases Published by Team from Cedars-Sinai Smidt Heart Institute
May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute…
Read More
By Mohammad Sahebjalal, MD
May 04, 2023
Radiation Scatter 101: Risks, Dangers and Latest Solutions
 Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video…
Read More
This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval
May 04, 2023
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the…
Read More
Investigators are one step closer to achieving this breakthrough in preventive healthcare and offering patients personalized predictions of their heart health thanks to a novel deep-learning tool and artificial intelligence (AI) algorithm developed at Cedars-Sinai.
May 04, 2023
New AI Tool Developed at Cedars-Sinai Can Predict Adverse Cardiac Events Like Heart Attacks, and Show How Risk Changes Over Time
May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or…
Read More
Transaction values Avertix at an enterprise value of $195 million
May 04, 2023
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long…
Read More
A team led by researchers at The University of Texas at Austin has developed an ultrathin, lightweight electronic tattoo, or e-tattoo, that attaches to the chest for continuous, mobile heart monitoring outside of a clinical setting
May 03, 2023
Chest e-Tattoo Boasts Major Improvements in Heart Monitoring
May 3, 2023 — A new flexible, wearable medical device could provide a major boost in the fight against heart disease,…
Read More
The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that Martha Gulati, MD, FACC, FAHA, FASPC, FESC has been named the recipient of the 2023 Arthur S. Agatston Cardiovascular Disease Prevention Award
May 03, 2023
SCCT Honors Dr. Martha Gulati with 2023 Arthur S. Agatston Award
May 3, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) Board of Directors is proud to announce that…
Read More
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP Platform
May 03, 2023
BioSig to Highlight New Data from the PURE EP Platform at Heart Rhythm 2023
May 3, 2023 — BioSig Technologies, Inc., a medical technology company delivering unprecedented accuracy and precision…
Read More
MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end
May 02, 2023
Sequana Medical Announces FDA Clearance of IND Application for DSR 2.0 for Treatment of Congestive Heart Failure
May 2, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now